Vibegron for treating overactive bladder

Vibegron is in clinical development for the treatment of Overactive Bladder (OAB). OAB can occur with a range of symptoms, including a sense of urgency to urinate, this can be accompanied with urinary incontinence, called wet OAB or no urinary incontinence, called dry OAB. Most often patients with OAB also experience increased frequency of urination and nocturia (waking through the night to urinate). Healthcare providers in England try to alleviate symptoms of OAB by advising patients to undertake bladder training exercises and to alter other lifestyle habits. If this does not improve symptoms, patients may be prescribed a medicinal product called anticholinergics, but the long-term side effects of taking these are not fully understood and carry a high risk of adverse events.